Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. HUBS
4. NUE
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
(NASDAQ: CRVS) Delayed: 12.56 +0.01 (0.08%)
Previous Close $12.55    52 Week High $17.77 
Open $12.53    52 Week Low $9.63 
Day High $12.61    P/E N/A 
Day Low $12.25    EPS $0.00 
Volume 4,460,675